The Thailand-based company operates a 2000 m2 production plant is produces growth factors and humanized therapeutic antibodies based on mammalian cell culture. Expected sales in 2013 are 400 million RMB.

China Bio news release, Sept. 26, 2013

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny